JOHN HOPE FRANKLIN CENTER
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
TXA vs. Amicar in Total Knee and Hip Arthroplasty
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Duke University
- Target Recruit Count
- 246
- Registration Number
- NCT02030821
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)
Not Applicable
Terminated
- Conditions
- ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATIONBenign and Malignant Mediastinal and Hilar Lymph Nodes Known or Suspected Malignancy
- Interventions
- Procedure: ROSEDevice: 22 gauge Vizishot needles
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Duke University
- Target Recruit Count
- 37
- Registration Number
- NCT02028052
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
Not Applicable
Terminated
- Conditions
- Metastatic Renal Cell CarcinomaGenitourinary Cancer (Bladder, Prostate or Testicular)
- Interventions
- Device: RNA extraction and amplification from biopsy specimens
- First Posted Date
- 2014-01-03
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 14
- Registration Number
- NCT02026960
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method
Not Applicable
Completed
- Conditions
- Metastatic Progressive Castration-resistant Prostate CancerMetastatic Progressive Breast Cancer
- Interventions
- Device: Mesenchymal-marker based ferrofluid (N-cadherin or O-cadherin based)
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2018-12-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 46
- Registration Number
- NCT02025413
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Phenylephrine Versus Ephedrine in Pre-eclampsia
- First Posted Date
- 2014-01-01
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 13
- Registration Number
- NCT02025426
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology
Not Applicable
Withdrawn
- Conditions
- Prostate Cancer
- Interventions
- Device: Near infrared (NIR) emissive nanotechnology
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Duke University
- Registration Number
- NCT02022904
Clinical Evaluation of Direct Dorsal Column Stimulation
Not Applicable
Terminated
- Conditions
- Failed Back Surgery Syndrome
- Interventions
- Device: Epidural trial leadDevice: Subdural trial lead
- First Posted Date
- 2013-12-25
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Duke University
- Target Recruit Count
- 6
- Registration Number
- NCT02020460
- Locations
- 🇺🇸
Duke University Health Systems, Durham, North Carolina, United States
Magnetic Resonance Imaging (MRI) in Motion
Completed
- Conditions
- Liver Cancer, Lung Cancer, Pancreatic Cancer
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- Duke University
- Target Recruit Count
- 25
- Registration Number
- NCT02019199
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
Phase 2
Completed
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- Procedure: Placement of the sponge
- First Posted Date
- 2013-12-20
- Last Posted Date
- 2018-02-09
- Lead Sponsor
- Duke University
- Target Recruit Count
- 100
- Registration Number
- NCT02016898
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 70
- Registration Number
- NCT02015546
- Locations
- 🇺🇸
Duke University Medical Center / Civitan Building, Durham, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath